Metraipolis › archive › dc_888a58366af6

qHBsAg outperforms ALT/qHBsAg ratio in predicting HBsAg seroclearance after cessation of entecavir versus tenofovir — Europe PMC PMID:41539474

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41539474
DOI
10.1016/j.bj.2026.100945
License (as archived)
solo-consultazione
Archived
2026-11-06T20:26:15.478Z
SHA-256 of the archived text
166b8ae048f9b69da07d02faee75de9101d5a7899d178c0656029cfec32b65c0
Stable URL of this page
https://metraipolis.com/documento/dc_888a58366af6

How to cite

qHBsAg outperforms ALT/qHBsAg ratio in predicting HBsAg seroclearance after cessation of entecavir versus tenofovir — Europe PMC PMID:41539474 — Europe PMC (en), https://europepmc.org/article/MED/41539474 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_888a58366af6 (Metraipolis archive dc_888a58366af6, sha256 166b8ae048f9b69da07d02faee75de9101d5a7899d178c0656029cfec32b65c0)
BibTeX
@misc{dc888a58366af6,
  title = {qHBsAg outperforms ALT/qHBsAg ratio in predicting HBsAg seroclearance after cessation of entecavir versus tenofovir — Europe PMC PMID:41539474},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41539474},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_888a58366af6; sha256 166b8ae048f9b69da07d02faee75de9101d5a7899d178c0656029cfec32b65c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41539474. Agents can read the archived copy with the MCP tool read_document.